A Single-Center, Single-Blind, Randomized, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Oral Doses of AZD1305 Extended-Release Capsules in Healthy Male Japanese and Caucasian Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2010
At a glance
- Drugs AZD 1305 (Primary)
- Indications Arrhythmias
- Focus Adverse reactions
- Acronyms JMAD
- 06 Dec 2010 Planned end date changed from 1 Feb 2010 to 1 Nov 2009 as reported by ClinicalTrials.gov.
- 23 Dec 2009 Trial acronym JMAD identified as reported by ClinicalTrials.gov.
- 23 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.